Table 2

Overview of recent treatment patterns of gout in the USA

Total ambulatory visits, and visits to primary care versus specialists

Total number of ambulatory care visits

973 million

Number of visits for gout

3.9 million (0.4% of total)

Percentage of total visits for gout to:

Primary care

69%

Cardiologists

10%

'Other specialists or unknown'

<16%

Rheumatologists

<2%

Number of gout patient-specific anti-inflammatory prescriptions (absolute number of prescriptions/year)

Colchicine

~381,000

NSAIDs

~700,000

Prednisone

~341,000

Number of gout patient-specific urate-lowering prescriptions (absolute number of prescriptions/year)

Allopurinol

2.8 million

Probenecid

8,000

Demographics of allopurinol prescribing: percentage of gout patients that are:

Caucasian

80%

African Americans

49%

Asians

19%


Data from the 2002 calendar year extracted from the work of Krishnan et al. [4]. NSAID, nonsteroidal anti-inflammatory drug.

Terkeltaub Arthritis Research & Therapy 2009 11:236   doi:10.1186/ar2738